कौन ज़िम्मेदार? KaunZimmedar

Quad commits to 1 billion vaccines via India's Biological E facility by year-end

This is a joint statement issued by the Foreign Ministers of Australia, India, and Japan, and the US Secretary of State following their fourth meeting in Melbourne on 11 February 2022. It reaffirms the Quad's commitment to supporting a free and open Indo-Pacific and outlines progress in areas such as vaccine production, maritime security, and counter-terrorism.

The statement involves the governments of Australia, India, Japan, and the United States. It affects or names ASEAN (specifically Cambodia as 2022 Chair), Tonga, Myanmar, North Korea, and regional partners in the Indo-Pacific. Sectors and groups mentioned include healthcare workers, vaccine manufacturers (Biological E Ltd), maritime agencies, and strategic thinkers.

  • Quad partners have collectively provided more than 500 million vaccine doses and pledged to donate more than 1.3 billion doses globally.
  • Expansion of vaccine production at the Biological E Ltd facility in India aims to deliver at least 1 billion vaccines by the end of 2022.
  • First batch of Quad-supported vaccines expected in the first half of 2022.
  • Australia proposed to host an Indo-Pacific Clean Energy Supply Chain Forum in mid-2022.
  • Japan will host the next Quad Leaders’ Summit in the first half of 2022.
  • Commitment to support ASEAN’s Outlook on the Indo-Pacific and Cambodia’s role as 2022 ASEAN Chair.

Written from the document by AI, and checked against it. The original below is authoritative.

The original document

Agreement 11 February, 2022
Document details
Official titleJoint statement by the Foreign Ministers of Australia, India and Japan and the Secretary of State of the United States following the 4th Quad Foreign Ministers’ Meeting
Source bodyMinistry of External Affairs — bilateral & trade documents
Reference number34854
Statusclosed (agreement)
Year2022
Closing date11 February, 2022
Documents1

Discussion (0)

Citizens discussing these documents. A discussion space — nothing here is verified fact or an official finding. Reading is free; sign in to take part.

Open discussion (0) →